HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$0.74
Day range
$0.73 - $0.85
Year range
$0.67 - $80.96
Market cap
3.18M USD
Avg Volume
1.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.98M | 94.62% |
Net income | -6.83M | -346.45% |
Net profit margin | — | — |
Earnings per share | -9.95 | 79.70% |
EBITDA | -6.88M | 9.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.25M | -59.53% |
Total assets | 17.63M | -49.59% |
Total liabilities | 11.53M | -1.60% |
Total equity | 6.10M | — |
Shares outstanding | 4.08M | — |
Price to book | 0.08 | — |
Return on assets | -82.21% | — |
Return on capital | -117.89% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.83M | -346.45% |
Cash from operations | -6.65M | -245.66% |
Cash from investing | — | — |
Cash from financing | -3.00K | 99.84% |
Net change in cash | -6.65M | -347.09% |
Free cash flow | -4.16M | -58.67% |
About
Founded
2016
Headquarters
Website
Employees
40